Botulinum Toxin Type A has become a pivotal agent in modern dermatology, finding applications that range from the correction of dynamic rhytides to adjunctive procedures in surgical settings.

Botulinum toxin type A (BTX-A) has emerged as a promising agent in both scar management and wound healing. By inducing temporary muscular paralysis, BTX-A reduces tension across wound edges, thereby ...

Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...

Source: Getty Images Long-term post-prostatectomy urinary incontinence affects 3% to 10% of patients. Intravesical botulinum toxin treatment for post-prostatectomy overactive bladder (OAB) appears ...

The use of toxin botulinum-A is one of the most rapidly growing areas in cosmetic dermatology. There is always news about this incredible substance. There are new indications, new techniques, and new ...

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it has partnered ...

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has commenced the commercial launch of Nuceiva® (botulinum ...

Please provide your email address to receive an email when new articles are posted on . Some botulinum toxin type A injection formulations have a faster onset, whereas others were shown to last longer ...

Patients with chronic illnesses face a significantly higher risk of complications from cosmetic botulinum toxin injections, ...

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has commenced the commercial launch of Nuceiva® (botulinum toxin type A) in Italy. The product is ...

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it has partnered with Symatese to commence distribution of ...

While rare, botulism can cause paralysis and is potentially fatal. It is caused by nerve-damaging toxins produced by Clostridium botulinum -- the most potent toxins known. These toxins are often found ...